Cargando…
Emerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading?
Malignant pleural mesothelioma (MPM) is an uncommon but aggressive and treatment resistant neoplasm with low survival rates. In the last years we assisted to an exponential growth in the appreciation of mesothelioma pathobiology, leading several new treatments to be investigated both in the early st...
Autores principales: | Cantini, Luca, Hassan, Raffit, Sterman, Daniel H., Aerts, Joachim G. J. V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080957/ https://www.ncbi.nlm.nih.gov/pubmed/32226777 http://dx.doi.org/10.3389/fonc.2020.00343 |
Ejemplares similares
-
Cellular Immunotherapy and Locoregional Administration of CAR T-Cells in Malignant Pleural Mesothelioma
por: Belderbos, Robert A., et al.
Publicado: (2020) -
Malignant Pleural Mesothelioma Nodal Status: Where Are We at?
por: Ricciardi, Sara, et al.
Publicado: (2021) -
Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020) -
First-ever Abscopal Effect after Palliative Radiotherapy and Immuno-gene Therapy for Malignant Pleural Mesothelioma
por: Barsky, Andrew R, et al.
Publicado: (2019) -
Immune Microenvironment and Genetics in Malignant Pleural Mesothelioma
por: Wadowski, Benjamin, et al.
Publicado: (2021)